Coronavirus Update: BMS Expands Medicine Program, Cancer Research UK Cuts Funding

Korean researchers also look at stem cells and vaccines

08 Apr 2020

• By Scrip Team

Bristol-Myers Squibb is to give away more medicines to uninsured US patients, Cancer Research UK tells of funding hardship, Oxford Biomedica joins a consortium to rapidly develop a vaccine, while a Korean company works on a stem cell therapy.

Bristol-Myers Squibb Co. is expanding its patient support programs to provide free access to any of its branded medicines to unemployed patients in the US who have lost their health insurance due to the COVID-19 pandemic. The company announced the expanded program on 7 April.

There are no financial requirements for eligibility into the expanded program, and patients would be asked to provide proof of...